CAD 0.15
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.1 Million CAD | -21.2% |
2022 | 1.39 Million CAD | -63.85% |
2021 | 3.86 Million CAD | -35.41% |
2020 | 5.99 Million CAD | 416.82% |
2019 | 1.15 Million CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q4 | 1.1 Million CAD | -3.39% |
2023 Q1 | 1.32 Million CAD | -5.12% |
2023 Q2 | 1.17 Million CAD | -11.37% |
2023 Q3 | 1.14 Million CAD | -3.0% |
2022 Q1 | 3.28 Million CAD | -15.12% |
2022 Q4 | 1.39 Million CAD | -51.56% |
2022 Q3 | 2.88 Million CAD | -6.82% |
2022 Q2 | 3.09 Million CAD | -5.64% |
2022 FY | 1.39 Million CAD | -63.85% |
2021 Q2 | 4.97 Million CAD | -7.3% |
2021 FY | 3.86 Million CAD | -35.41% |
2021 Q4 | 3.86 Million CAD | -12.86% |
2021 Q3 | 4.44 Million CAD | -10.74% |
2021 Q1 | 5.36 Million CAD | -10.41% |
2020 Q4 | 5.99 Million CAD | 0.0% |
2020 FY | 5.99 Million CAD | 416.82% |
2019 FY | 1.15 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | 4.19 Million CAD | 73.717% |
Asep Medical Holdings Inc | 25.61 Million CAD | 95.697% |
BetterLife Pharma Inc. | 324.74 Thousand CAD | -239.413% |
BioVaxys Technology Corp. | 113.47 Thousand CAD | -871.317% |
ChitogenX Inc. | 534 Thousand CAD | -106.41% |
Rapid Dose Therapeutics Corp. | 1.88 Million CAD | 41.531% |
Defence Therapeutics Inc. | 477.74 Thousand CAD | -130.714% |
Entheon Biomedical Corp. | 401.07 Thousand CAD | -174.818% |
Gemina Laboratories Ltd. | 1.45 Million CAD | 24.312% |
Glow Lifetech Corp. | 1.91 Million CAD | 42.383% |
Lexston Life Sciences Corp. | 750.94 Thousand CAD | -46.778% |
Pharmala Biotech Holdings Inc. | 2.41 Million CAD | 54.312% |
MYND Life Sciences Inc. | 797.54 Thousand CAD | -38.203% |
Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -3448.83% |
PharmaTher Holdings Ltd. | 2.58 Million CAD | 57.439% |
PreveCeutical Medical Inc. | 181.51 Thousand CAD | -507.256% |
Telescope Innovations Corp. | 3.02 Million CAD | 63.545% |